<DOC>
	<DOCNO>NCT00115973</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . This in-patient trial investigate stepwise dose increase period 3-weeks follow 10-week out-patient maintenance period . A telephone contact visit schedule follow-up final clinic visit . A subject 's participation trial would expect 16 week .</brief_summary>
	<brief_title>A Study Treatment Type 2 Diabetes With Insulin Infusion Pump</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 2 diabetes diagnosis least 2 year ago Body Mass Index ( BMI ) : 2640 kg/m^2 ( inclusive ) HbA1c : 7.510 % ( inclusive ) FPG value least 140 mg/dl ( 7.8 mmol/l ) Use drug , may interfere interpretation trial result know cause clinically relevant interference insulin action glucose utilization ( steroid nonspecific betablockers ) Current addiction alcohol substance abuse positive result urine screen drug alcohol use Known suspect allergy trial product relate product</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pump</keyword>
	<keyword>Diabetes</keyword>
</DOC>